Tag: Merck

• Wednesday, August 19th 2026 - 21:47 UTC

  A personalized mRNA therapy passes a phase 3 melanoma trial for the first time

  

  Pharmaceutical companies Merck, known as MSD outside the United States and Canada, and Moderna announced on Wednesday that their individualized neoantigen therapy, intismeran autogene, met its endpoints in a phase 3 trial in melanoma patients. It is the first positive result at that stage for an mRNA-based cancer treatment.

• Tuesday, November 30th 2021 - 18:34 UTC

  Pill to treat COVID-19 cleared for distribution within Paraguay

  

  A pill to treat COVID-19 patients can now be distributed throughout Paraguay's conventional pharmaceutical network after two local laboratories were granted a registration license to manufacture Molnupiravir, the pill developed by Merck.

• Tuesday, November 16th 2021 - 16:53 UTC

  Patents of Pfizer's pill against C-19 free for other labs to use

  

  World Health Organization (WHO) partners Unitaid have announced an agreement with the Pfizer laboratories to manufacture generic oral drugs to be used against COVID-19.

• Friday, November 5th 2021 - 08:55 UTC

  UK green-lights use of Merck's COVID-19 pill

  

  The United Kingdom Thursday became the first country in the world to authorize the use of molnupiravir, a pill developed by US laboratories Merck, to treat COVID-19.